Sagility Limited (NSE:SAGILITY)
India · Delayed Price · Currency is INR 40.49
+1.00 (2.53%)
Jun 22, 2026, 10:10 AM IST
Sagility Revenue
In the fiscal year ending March 31, 2026, Sagility had annual revenue of 71.93B INR with 29.14% growth. Sagility had revenue of 20.24B in the quarter ending March 31, 2026, with 29.06% growth.
Revenue
71.93B
Revenue Growth
+29.14%
P/S Ratio
2.57
Revenue / Employee
1.53M
Employees
46,860
Market Cap
184.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 71.93B | 16.23B | 29.14% |
| Mar 31, 2025 | 55.70B | 8.16B | 17.17% |
| Mar 31, 2024 | 47.54B | 5.35B | 12.69% |
| Mar 31, 2023 | 42.18B | 28.33B | 204.55% |
| Mar 31, 2022 | 13.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Piramal Pharma | 88.69B |
| NATCO Pharma | 40.78B |
| Syngene International | 37.39B |
| Eris Lifesciences | 31.15B |
Sagility News
- 5 weeks ago - Sagility Transcript: Q4 25/26 - Transcripts
- 5 weeks ago - Sagility Quarterly report: Q4 2026 - Filings
- 5 weeks ago - Sagility Slides: Q4 2026 - Filings
- 3 months ago - Sagility Transcript: Investor Day 2026 - Transcripts
- 3 months ago - Sagility Slides: FY 2026 - Filings
- 3 months ago - Sagility Slides: Investor presentation - Filings
- 5 months ago - Sagility Transcript: Q3 25/26 - Transcripts
- 5 months ago - Sagility Quarterly report: Q3 2026 - Filings